Chuck De La Mater - Founder/Chairman
Dr. Kevin Tehrani - Medical Director
Val Naona - Business Development
Our founder and chairman Chuck De La Mater has been a dialysis patient since 2005. With passion and determination, FLB ReGenesis was created to research, improve, promote and deliver better patient outcomes utilizing the latest innovative regenerative medicine technologies to the more than 120 million patients diagnosed with Diabetes and Hypertension, the leading causes of Chronic Kidney Disease.
FLB ReGenesis manages companies and projects in the burgeoning regenerative medical arena. FLB ReGenesis is focused primarily on the prevention of Chronic Kidney Disease by identifying and treating the early symptoms of Diabetes and Hypertension and early 1st, 2nd and 3rd stage CKD patients that eventually advance to End Stage Renal Disease (ESRD) requiring dialysis or kidney transplant to live.
and would like to see if you are a candidate for regenerative medical treatments or qualify for our IRB clinical trials, please register and submit your comments.
4160 Temescal Canyon Rd, Suite 500, Corona, CA 92283, US